- Home
- ATER vs KAPA Comparison
ATER vs KAPA Comparison
Compare ATER & KAPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATER
- KAPA
- Stock Information
- Founded
- ATER 2014
- KAPA 2013
- Country
- ATER United States
- KAPA United States
- Employees
- ATER N/A
- KAPA N/A
- Industry
- ATER Home Furnishings
- KAPA
- Sector
- ATER Consumer Discretionary
- KAPA
- Exchange
- ATER Nasdaq
- KAPA NYSE
- Market Cap
- ATER 22.8M
- KAPA 18.8M
- IPO Year
- ATER N/A
- KAPA 2024
- Fundamental
- Price
- ATER $2.06
- KAPA $1.27
- Analyst Decision
- ATER Strong Buy
- KAPA Strong Buy
- Analyst Count
- ATER 1
- KAPA 1
- Target Price
- ATER N/A
- KAPA $9.00
- AVG Volume (30 Days)
- ATER 80.8K
- KAPA 969.6K
- Earning Date
- ATER 03-11-2025
- KAPA 03-04-2025
- Dividend Yield
- ATER N/A
- KAPA N/A
- EPS Growth
- ATER N/A
- KAPA N/A
- EPS
- ATER N/A
- KAPA N/A
- Revenue
- ATER $107,193,000.00
- KAPA N/A
- Revenue This Year
- ATER N/A
- KAPA N/A
- Revenue Next Year
- ATER $5.47
- KAPA N/A
- P/E Ratio
- ATER N/A
- KAPA N/A
- Revenue Growth
- ATER N/A
- KAPA N/A
- 52 Week Low
- ATER $0.23
- KAPA $0.85
- 52 Week High
- ATER $3.95
- KAPA $4.00
- Technical
- Relative Strength Index (RSI)
- ATER 41.40
- KAPA N/A
- Support Level
- ATER $2.10
- KAPA N/A
- Resistance Level
- ATER $2.31
- KAPA N/A
- Average True Range (ATR)
- ATER 0.18
- KAPA 0.00
- MACD
- ATER -0.00
- KAPA 0.00
- Stochastic Oscillator
- ATER 31.25
- KAPA 0.00
About ATER Aterian Inc.
Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products and, consumer electronics. It has various owned and operated brands including Vremi, Healing Solutions, Xtava, TRUWEO, Spiralize, Pohl+Schmitt, and RIF6. The company generates revenue through the online sales of various consumer products that are sold online.
About KAPA KAIROS PHARMA LTD
Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. It is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma.